BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15334867)

  • 1. Erythropoietic agents in the management of cancer patients. Part 1: Anemia, quality of life, and possible effects on survival.
    Smith RE
    J Support Oncol; 2003; 1(4):249-56, 258-9; discussion 257-8. PubMed ID: 15334867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of epoetin in the management of anaemia in patients with lung cancer.
    Morère JF
    Lung Cancer; 2004 Nov; 46(2):149-56. PubMed ID: 15474662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. rHuEPO and treatment outcomes: the clinical experience.
    Hudis CA; Van Belle S; Chang J; Muenstedt K
    Oncologist; 2004; 9 Suppl 5():55-69. PubMed ID: 15591423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence-based medicine: can it be applied to stimulation of erythropoiesis for patients with malignancy?
    Rizzo JD
    Best Pract Res Clin Haematol; 2005; 18(3):439-48. PubMed ID: 15792918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EPO in cancer anemia: benefits and potential risks.
    Milano M; Schneider M
    Crit Rev Oncol Hematol; 2007 May; 62(2):119-25. PubMed ID: 17197190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The blue cross blue shield assessment technology review: summary of findings.
    Bennett CL
    Best Pract Res Clin Haematol; 2005; 18(3):423-31. PubMed ID: 15792916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietic agents in the management of cancer patients. Part 2: studies on their role in neuroprotection and neurotherapy.
    Smith RE
    J Support Oncol; 2004; 2(1):39-49. PubMed ID: 15330371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin-stimulating agents in oncology.
    Savona MR; Silver SM
    Cancer J; 2008; 14(2):75-84. PubMed ID: 18391611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical and clinical effects of erythropoietin in the management of anaemia in patients with non-small cell lung cancer.
    Dempke W
    Anticancer Res; 2007; 27(4A):1745-57. PubMed ID: 17649769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CERA (Continuous Erythropoietin Receptor Activator): a new erythropoiesis-stimulating agent for the treatment of anemia.
    Macdougall IC
    Curr Hematol Rep; 2005 Nov; 4(6):436-40. PubMed ID: 16232379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antianemic effect of once weekly regimen of epoetin alfa 40,000 units in anemic cancer patients receiving chemotherapy.
    Voravud N; Sriuranpong V; Suwanrusme H
    J Med Assoc Thai; 2007 Jun; 90(6):1082-8. PubMed ID: 17624200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietin in cancer patients.
    Glaspy JA
    Annu Rev Med; 2009; 60():181-92. PubMed ID: 18980468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythropoietin in cancer: presumption of innocence?
    Blau CA
    Stem Cells; 2007 Aug; 25(8):2094-7. PubMed ID: 17464082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anemia and the elderly: clinical considerations.
    Gabrilove J
    Best Pract Res Clin Haematol; 2005; 18(3):417-22. PubMed ID: 15792915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. rHuEPO and improved treatment outcomes: potential modes of action.
    Blackwell K; Gascón P; Sigounas G; Jolliffe L
    Oncologist; 2004; 9 Suppl 5():41-7. PubMed ID: 15591421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Erythropoietic protein supportive treatment in small cell lung cancer].
    Tamási L; Müller V; Magyar P; Losonczy G
    Magy Onkol; 2008 Mar; 52(1):43-6. PubMed ID: 18403296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythroid-stimulating agents in cancer therapy: potential dangers and biologic mechanisms.
    Hadland BK; Longmore GD
    J Clin Oncol; 2009 Sep; 27(25):4217-26. PubMed ID: 19636005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epoetin beta therapy in patients with solid tumours.
    Pronzato P; Jassem J; Mayordomo J
    Crit Rev Oncol Hematol; 2006 Apr; 58(1):46-52. PubMed ID: 16169242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anemia impact on treatments of cervical carcinomas].
    Marchal C; Rangeard L; Brunaud C
    Cancer Radiother; 2005 Mar; 9(2):87-95. PubMed ID: 15820436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of response and other improvements on the limitations of recombinant human erythropoietin therapy in anemic cancer patients.
    Beguin Y
    Haematologica; 2002 Nov; 87(11):1209-21. PubMed ID: 12414352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.